Cancers | Free Full-Text | Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and Oncologists
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect
JPM | Free Full-Text | Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry in Lung Cancer - ILCN.org (ILCN/WCLC)
Tumor type and expression of markers in lung cancer cases. | Download Table
Immunohistochemistry in lung cancer
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System
Immunohistochemical Tumor Markers | Proteins That Help Diagnose Mesothelioma
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink
Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified | SpringerLink
Pathology and personalized medicine in lung cancer | Lung Cancer Management
SciELO - Brasil - Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry
Simultaneous Multi-Antibody Staining in Non-Small Cell Lung Cancer Strengthens Diagnostic Accuracy Especially in Small Tissue Samples | PLOS ONE
Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology - Righi - 2011 - Cancer - Wiley Online Library
Immunohistochemistry (IHC) and Lung Cancer: An introduction with Moose and Doc
Abandoning the Notion of Non-Small Cell Lung Cancer: Trends in Molecular Medicine
Cellular and Molecular Pathology of Lung Cancer | Thoracic Key
Immunohistochemistry in lung cancer
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Mult
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
Lung cancer biomarkers | Abcam
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium | Haematologica
Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles | BMC Cancer | Full Text
